Efficacy of cyclosporine treatment on severe recalcitrant nodular vasculitis

2020 ◽  
Vol 33 (6) ◽  
Author(s):  
RuiXian Ye ◽  
Xin Tian ◽  
XiBao Zhang
Keyword(s):  



2008 ◽  
Vol 47 ◽  
pp. 3-6 ◽  
Author(s):  
Annet Westers-Attema ◽  
A. van Tubergen ◽  
H. Plasschaert ◽  
A. M. W. van Marion ◽  
J. Frank ◽  
...  


2003 ◽  
Vol 42 (8) ◽  
pp. 639-642 ◽  
Author(s):  
Amor Khachemoune ◽  
M. Isabel Longo ◽  
Tania J. Phillips
Keyword(s):  


Dermatology ◽  
2018 ◽  
Vol 235 (2) ◽  
pp. 137-143 ◽  
Author(s):  
Florian Anzengruber ◽  
Caroline Mergenthaler ◽  
Carla Murer ◽  
Reinhard Dummer

Objectives: Potassium iodide (KI) is a medication that has been used for decades in dermatology and it is mentioned as a treatment option in all major dermatology textbooks. Yet, there is little recent information on its efficacy. In our study, we wanted to retrospectively evaluate the therapy response to KI in our patients. Methods: The hospital information system was searched for patients treated with KI at the Department of Dermatology (University Hospital Zurich) in the last 20 years (January 1, 1998 to December 31, 2017). A total of 52 patients were found and, subsequently, 35 patients were included in our study. Results: KI was prescribed for the following skin conditions: erythema nodosum, disseminated granuloma anulare, necrobiosis lipoidica, nodular vasculitis, cutaneous sarcoidosis, and granulomatous perioral dermatitis/ rosacea. The median duration of KI intake was 5 ± 7.7 weeks (range 1–26). The global assessment of efficacy by the treating physician showed an improvement of disease in about a third of all patients. No response was seen in 14 patients and 9 even had a progression of disease. An adverse event was documented in 16 cases. Conclusions: Our findings show that an improvement was reached in only about a third of all cases. High response rates with only mild side effects (in 16 out of 35 patients) were observed.



2017 ◽  
Vol 27 (4) ◽  
pp. 410-412 ◽  
Author(s):  
Miho Kabuto ◽  
Gen Nakanishi ◽  
Hiromi Kimura ◽  
Toshihiro Tanaka ◽  
Noriki Fujimoto


Author(s):  
Michael Marker1 ◽  
Susana Ortiz-Urda2 ◽  
Nikolaus Lilgenau1 ◽  
Klemens Rappersberger1


2015 ◽  
Vol 53 (200) ◽  
pp. 298-300 ◽  
Author(s):  
Sudip Parajuli ◽  
Kamal Raj Dhital

We report a case of recalcitrant nodular vasculitis in a 23 years old male who was treated successfully with methotrexate. He presented to our Dermatology out Patient Department, Tribhuvan university teaching hospital with complaints of recurrent painful discharging ulcer over bilateral calf and lower legs of three years duration. The diagnosis of nodular vasculitis was made on the basis of the clinical presentation and the histopathological findings. The patient was treated with antituberculosis treatment with initial good response; however the lesions persisted later on, despite completing the course of ATT. The patient did not respond to treatment with systemic corticosteroids also. On starting methotrexate, the lesion started healing within a period of two weeks and therewas significant improvement in subsequent one month. This case report highlights the efficacy of methotrexate in the treatment of recalcitrant nodular vasculitis.  Keywords: ATT; methotrexate; nodular vasculitis.



1993 ◽  
Vol 32 (2) ◽  
pp. 108-112 ◽  
Author(s):  
MARIA-DOLORES SANZ VICO ◽  
VICTOR DIEGO ◽  
EVARISTO SÁNCHEZ YUS




Sign in / Sign up

Export Citation Format

Share Document